Literature DB >> 17087854

Stress signaling in the heart by AMP-activated protein kinase.

Raymond Russell1.   

Abstract

The stress-signaling protein, adenosine monophosphate-activated protein kinase (AMPK), regulates a variety of pathways in cells that 1) increase the provision and utilization of energy-providing substrates such as glucose and fatty acids, 2) inhibit energy-requiring pathways such as cholesterol biosynthesis and protein synthesis, and 3) increase the transcription of genes involved in energy metabolism and mitochondrial biogenesis. In the heart, AMPK therefore becomes very important in protecting against ischemia-reperfusion injury and regulating substrate metabolism in the face of changes in workload. This review summarizes the regulation of AMPK activity in the heart and discusses the effects of AMPK activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17087854     DOI: 10.1007/s11906-006-0021-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  64 in total

1.  The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells.

Authors:  Z Dagher; N Ruderman; K Tornheim; Y Ido
Journal:  Biochem Biophys Res Commun       Date:  1999-11       Impact factor: 3.575

2.  Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity.

Authors:  Asensio A Gonzalez; Reetu Kumar; Jacob D Mulligan; Ashley J Davis; Richard Weindruch; Kurt W Saupe
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-07-13       Impact factor: 4.310

Review 3.  The AMP-activated protein kinase--fuel gauge of the mammalian cell?

Authors:  D G Hardie; D Carling
Journal:  Eur J Biochem       Date:  1997-06-01

4.  Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation.

Authors:  Yasuo Ido; David Carling; Neil Ruderman
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

5.  The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

Authors:  Lee G D Fryer; Asha Parbu-Patel; David Carling
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

6.  Myocardial ischemia differentially regulates LKB1 and an alternate 5'-AMP-activated protein kinase kinase.

Authors:  Judith Y Altarejos; Masayuki Taniguchi; Alexander S Clanachan; Gary D Lopaschuk
Journal:  J Biol Chem       Date:  2004-10-26       Impact factor: 5.157

7.  AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment.

Authors:  Gregory R Steinberg; James W E Rush; David J Dyck
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-11-19       Impact factor: 4.310

8.  Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase.

Authors:  Yanqiu Xing; Nicolas Musi; Nobuharu Fujii; Liqun Zou; Ivan Luptak; Michael F Hirshman; Laurie J Goodyear; Rong Tian
Journal:  J Biol Chem       Date:  2003-05-23       Impact factor: 5.157

9.  Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK).

Authors:  Kay Barnes; Jean C Ingram; Omar H Porras; L Felipe Barros; Emma R Hudson; Lee G D Fryer; Fabienne Foufelle; David Carling; D Grahame Hardie; Stephen A Baldwin
Journal:  J Cell Sci       Date:  2002-06-01       Impact factor: 5.285

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  5 in total

1.  Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke.

Authors:  Jun Li; Zhiyuan Zeng; Benoit Viollet; Gabriele V Ronnett; Louise D McCullough
Journal:  Stroke       Date:  2007-09-27       Impact factor: 7.914

2.  Dual control of cardiac Na+ Ca2+ exchange by PIP(2): analysis of the surface membrane fraction by extracellular cysteine PEGylation.

Authors:  Chengcheng Shen; Mei-Jung Lin; Alp Yaradanakul; Vincenzo Lariccia; Joseph A Hill; Donald W Hilgemann
Journal:  J Physiol       Date:  2007-05-31       Impact factor: 5.182

Review 3.  Cellular Stress and Molecular Responses in Bladder Ischemia.

Authors:  Jing-Hua Yang; Han-Pil Choi; Wanting Niu; Kazem M Azadzoi
Journal:  Int J Mol Sci       Date:  2021-11-01       Impact factor: 5.923

Review 4.  How AMPK and PKA Interplay to Regulate Mitochondrial Function and Survival in Models of Ischemia and Diabetes.

Authors:  Jingdian Zhang; Yumeng Wang; Xiaofeng Liu; Ruben K Dagda; Ying Zhang
Journal:  Oxid Med Cell Longev       Date:  2017-12-17       Impact factor: 6.543

5.  Impairment of AMPK-α2 augments detrusor contractions in bladder ischemia.

Authors:  Jing-Hua Yang; Wanting Niu; Yedan Li; Kazem M Azadzoi
Journal:  Investig Clin Urol       Date:  2021-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.